| Title: | Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations |
| Journal: | Genome Medicine |
| Published: | 24 Jan 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36694225/ |
| DOI: | https://doi.org/10.1186/s13073-023-01156-9 |
| URL: | https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-023-01156-9 |
| Citations: | 18 (18 in last 2 years) as of 8 Aug 2024 |
Publication 10994
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundThe genetic architectures of colorectal cancer are distinct across different populations. To date, the majority of polygenic risk scores (PRSs) are derived from European (EUR) populations, which limits their accurate extrapolation to other populations. Here, we aimed to generate a PRS by incorporating East Asian (EAS) and EUR ancestry groups and validate its utility for colorectal cancer risk assessment among different populations.MethodsA large-scale colorectal cancer genome-wide association study (GWAS), harboring 35,145 cases and 288,934 controls from EAS and EUR populations, was used for the EAS-EUR GWAS meta-analysis and the construction of candidate EAS-EUR PRSs via different approaches. The performance of each PRS was then validated in external GWAS datasets of EAS (727 cases and 1452 controls) and EUR (1289 cases and 1284 controls) ancestries, respectively. The optimal PRS was further tested using the UK Biobank longitudinal cohort of 355,543 individuals and ultimately applied to stratify individual risk attached by healthy lifestyle.ResultsIn the meta-analysis across EAS and EUR populations, we identified 48 independent variants beyond genome-wide significance (P < 5 × 10−8) at previously reported loci. Among 26 candidate EAS-EUR PRSs, the PRS-CSx approach-derived PRS (defined as PRSCSx) that harbored genome-wide variants achieved the optimal discriminatory ability in both validation datasets, as well as better performance in the EAS population compared to the PRS derived from known variants. Using the UK Biobank cohort, we further validated a significant dose-response effect of PRSCSx on incident colorectal cancer, in which the risk was 2.11- and 3.88-fold higher in individuals with intermediate and high PRSCSx than in the low score subgroup (Ptrend = 8.15 × 10−53). Notably, the detrimental effect of being at a high genetic risk could be largely attenuated by adherence to a favorable lifestyle, with a 0.53% reduction in 5-year absolute risk.ConclusionsIn summary, we systemically constructed an EAS-EUR PRS to effectively stratify colorectal cancer risk, which highlighted its clinical implication among diverse ancestries. Importantly, these findings also supported that a healthy lifestyle could reduce the genetic impact on incident colorectal cancer.</p>
19 Authors
- Junyi Xin
- Mulong Du
- Dongying Gu
- Kewei Jiang
- Mengyun Wang
- Mingjuan Jin
- Yeting Hu
- Shuai Ben
- Silu Chen
- Wei Shao
- Shuwei Li
- Haiyan Chu
- Linjun Zhu
- Chen Li
- Kun Chen
- Kefeng Ding
- Zhengdong Zhang
- Hongbing Shen
- Meilin Wang
1 Application
| Application ID | Title |
|---|---|
| 45611 | Genome-wide cross-trait analysis for genetic architecture of pan-cancer by UK Biobank |
Enabling scientific discoveries that improve human health